Chronic lymphocytic leukaemia: from genetics to treatment
F Bosch, R Dalla-Favera - Nature reviews Clinical oncology, 2019 - nature.com
Chronic lymphocytic leukaemia (CLL), the most frequent type of leukaemia in adults, is a
lymphoproliferative disorder that is characterized by the expansion of monoclonal, mature …
lymphoproliferative disorder that is characterized by the expansion of monoclonal, mature …
[HTML][HTML] Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies
Chronic lymphocytic leukemia is a well-defined lymphoid neoplasm with very
heterogeneous biological and clinical behavior. The last decade has been remarkably …
heterogeneous biological and clinical behavior. The last decade has been remarkably …
[HTML][HTML] IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies
J Bennett, DT Starczynowski - Current Opinion in Hematology, 2022 - journals.lww.com
IRAK-targeted therapies that have matriculated to early phase trials are yielding promising
preliminary results. However, studies of IRAK kinase signaling continue to defy conventional …
preliminary results. However, studies of IRAK kinase signaling continue to defy conventional …
[HTML][HTML] Toll-like receptors and cancer: MYD88 mutation and inflammation
JQ Wang, YS Jeelall, LL Ferguson… - Frontiers in …, 2014 - frontiersin.org
Pattern recognition receptors (PRRs) expressed on immune cells are crucial for the early
detection of invading pathogens, in initiating early innate immune response and in …
detection of invading pathogens, in initiating early innate immune response and in …
Biological and clinical relevance of associated genomic alterations in MYD88 L265P and non-L265P–mutated diffuse large B-cell lymphoma: analysis of 361 cases
S Dubois, PJ Viailly, E Bohers, P Bertrand… - Clinical Cancer …, 2017 - AACR
Purpose: MYD88 mutations, notably the recurrent gain-of-function L265P variant, are a
distinguishing feature of activated B-cell like (ABC) diffuse large B-cell lymphoma (DLBCL) …
distinguishing feature of activated B-cell like (ABC) diffuse large B-cell lymphoma (DLBCL) …
The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing
SH Swerdlow, I Kuzu, A Dogan, S Dirnhofer, JKC Chan… - Virchows Archiv, 2016 - Springer
Plasmacytic differentiation may occur in almost all small B cell lymphomas (SBLs), although
it varies from being uniformly present (as in lymphoplasmacytic lymphoma (LPL)) to very …
it varies from being uniformly present (as in lymphoplasmacytic lymphoma (LPL)) to very …
[HTML][HTML] Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia
The diagnosis of Waldenström's macroglobulinemia (WM), an IgM-associated
lymphoplasmacytic lymphoma, can be challenging due to the different forms of disease …
lymphoplasmacytic lymphoma, can be challenging due to the different forms of disease …
Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies
Y Kikushige - Journal of clinical and experimental hematopathology, 2020 - jstage.jst.go.jp
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in Western
countries and is characterized by the clonal expansion of mature CD5+ B cells. There have …
countries and is characterized by the clonal expansion of mature CD5+ B cells. There have …
[HTML][HTML] Precision diagnostics in chronic lymphocytic leukemia: Past, present and future
J Mollstedt, L Mansouri, R Rosenquist - Frontiers in Oncology, 2023 - frontiersin.org
Genetic diagnostics of hematological malignancies has evolved dramatically over the years,
from chromosomal banding analysis to next-generation sequencing, with a corresponding …
from chromosomal banding analysis to next-generation sequencing, with a corresponding …
MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity
J Schmidt, B Federmann, N Schindler… - British journal of …, 2015 - Wiley Online Library
Recurrent mutations in MYD 88 have been identified in> 90% of lymphoplasmacytic
lymphoma (LPL). Recently, WHIM (warts, hypogammaglobulinaemia, infections …
lymphoma (LPL). Recently, WHIM (warts, hypogammaglobulinaemia, infections …